Cargando…

Effects of 12‐week escitalopram treatment on resting‐state functional connectivity of large‐scale brain networks in major depressive disorder

In this study, the effects of antidepressants on large‐scale brain networks and the neural basis of individual differences in response were explored. A total of 41 patients with major depressive disorder (MDD) and 42 matched healthy controls (HCs) were scanned by resting‐state functional magnetic re...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Shudong, Zhou, Jingjing, Cui, Jian, Zhang, Zhifang, Liu, Rui, Feng, Yuan, Feng, Lei, Wang, Yun, Chen, Xiongying, Wu, Hang, Jin, Yuening, Zhou, Yuan, Wang, Gang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10028676/
https://www.ncbi.nlm.nih.gov/pubmed/36773284
http://dx.doi.org/10.1002/hbm.26231
_version_ 1784909998204125184
author Zhang, Shudong
Zhou, Jingjing
Cui, Jian
Zhang, Zhifang
Liu, Rui
Feng, Yuan
Feng, Lei
Wang, Yun
Chen, Xiongying
Wu, Hang
Jin, Yuening
Zhou, Yuan
Wang, Gang
author_facet Zhang, Shudong
Zhou, Jingjing
Cui, Jian
Zhang, Zhifang
Liu, Rui
Feng, Yuan
Feng, Lei
Wang, Yun
Chen, Xiongying
Wu, Hang
Jin, Yuening
Zhou, Yuan
Wang, Gang
author_sort Zhang, Shudong
collection PubMed
description In this study, the effects of antidepressants on large‐scale brain networks and the neural basis of individual differences in response were explored. A total of 41 patients with major depressive disorder (MDD) and 42 matched healthy controls (HCs) were scanned by resting‐state functional magnetic resonance imaging separately at baseline and after a 12‐week follow‐up. The patients with MDD received escitalopram for 12 weeks. After treatment, patients were classified into those with MDD in remission [MDDr, endpoint 17‐item Hamilton Depression Rating Scale (HAMD) total score ≤7] and those in nonremission (MDDnr). The human Brainnetome Atlas was used to define large‐scale networks and compute within‐ and between‐network resting‐state functional connectivity (rsFC). Results showed the decreased subcortical network (SCN)–ventral attention network (VAN) connectivity at baseline increased in patients with MDD after 12‐week treatment, and it was comparable with that of HCs. This change was only observed in patients with MDDr. However, the decreased within‐network rsFC in SCN and default mode network (DMN) persisted in all patients with MDD, including those with MDDr and MDDnr, after treatment. The strength of SCN–VAN connectivity at baseline was significantly negatively correlated with the reduction rate of HAMD score in all patients with MDD. Thus, SCN–VAN connectivity may be an antidepressant target associated with depressive state changes and a predictor of treatment response to serotonin reuptake inhibitors. The within‐network rsFC in SCN and DMN may reflect a trait‐like abnormality in MDD. These findings provide further insights into the mechanism of antidepressants and their individual differences in response. The trial name is “Appropriate technology study of MDD diagnosis and treatment based on objective indicators and measurement” (URL: http://www.chictr.org.cn/showproj.aspx?proj=21377; registration number: ChiCTR‐OOC‐17012566).
format Online
Article
Text
id pubmed-10028676
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher John Wiley & Sons, Inc.
record_format MEDLINE/PubMed
spelling pubmed-100286762023-03-22 Effects of 12‐week escitalopram treatment on resting‐state functional connectivity of large‐scale brain networks in major depressive disorder Zhang, Shudong Zhou, Jingjing Cui, Jian Zhang, Zhifang Liu, Rui Feng, Yuan Feng, Lei Wang, Yun Chen, Xiongying Wu, Hang Jin, Yuening Zhou, Yuan Wang, Gang Hum Brain Mapp Research Articles In this study, the effects of antidepressants on large‐scale brain networks and the neural basis of individual differences in response were explored. A total of 41 patients with major depressive disorder (MDD) and 42 matched healthy controls (HCs) were scanned by resting‐state functional magnetic resonance imaging separately at baseline and after a 12‐week follow‐up. The patients with MDD received escitalopram for 12 weeks. After treatment, patients were classified into those with MDD in remission [MDDr, endpoint 17‐item Hamilton Depression Rating Scale (HAMD) total score ≤7] and those in nonremission (MDDnr). The human Brainnetome Atlas was used to define large‐scale networks and compute within‐ and between‐network resting‐state functional connectivity (rsFC). Results showed the decreased subcortical network (SCN)–ventral attention network (VAN) connectivity at baseline increased in patients with MDD after 12‐week treatment, and it was comparable with that of HCs. This change was only observed in patients with MDDr. However, the decreased within‐network rsFC in SCN and default mode network (DMN) persisted in all patients with MDD, including those with MDDr and MDDnr, after treatment. The strength of SCN–VAN connectivity at baseline was significantly negatively correlated with the reduction rate of HAMD score in all patients with MDD. Thus, SCN–VAN connectivity may be an antidepressant target associated with depressive state changes and a predictor of treatment response to serotonin reuptake inhibitors. The within‐network rsFC in SCN and DMN may reflect a trait‐like abnormality in MDD. These findings provide further insights into the mechanism of antidepressants and their individual differences in response. The trial name is “Appropriate technology study of MDD diagnosis and treatment based on objective indicators and measurement” (URL: http://www.chictr.org.cn/showproj.aspx?proj=21377; registration number: ChiCTR‐OOC‐17012566). John Wiley & Sons, Inc. 2023-02-11 /pmc/articles/PMC10028676/ /pubmed/36773284 http://dx.doi.org/10.1002/hbm.26231 Text en © 2023 The Authors. Human Brain Mapping published by Wiley Periodicals LLC. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Research Articles
Zhang, Shudong
Zhou, Jingjing
Cui, Jian
Zhang, Zhifang
Liu, Rui
Feng, Yuan
Feng, Lei
Wang, Yun
Chen, Xiongying
Wu, Hang
Jin, Yuening
Zhou, Yuan
Wang, Gang
Effects of 12‐week escitalopram treatment on resting‐state functional connectivity of large‐scale brain networks in major depressive disorder
title Effects of 12‐week escitalopram treatment on resting‐state functional connectivity of large‐scale brain networks in major depressive disorder
title_full Effects of 12‐week escitalopram treatment on resting‐state functional connectivity of large‐scale brain networks in major depressive disorder
title_fullStr Effects of 12‐week escitalopram treatment on resting‐state functional connectivity of large‐scale brain networks in major depressive disorder
title_full_unstemmed Effects of 12‐week escitalopram treatment on resting‐state functional connectivity of large‐scale brain networks in major depressive disorder
title_short Effects of 12‐week escitalopram treatment on resting‐state functional connectivity of large‐scale brain networks in major depressive disorder
title_sort effects of 12‐week escitalopram treatment on resting‐state functional connectivity of large‐scale brain networks in major depressive disorder
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10028676/
https://www.ncbi.nlm.nih.gov/pubmed/36773284
http://dx.doi.org/10.1002/hbm.26231
work_keys_str_mv AT zhangshudong effectsof12weekescitalopramtreatmentonrestingstatefunctionalconnectivityoflargescalebrainnetworksinmajordepressivedisorder
AT zhoujingjing effectsof12weekescitalopramtreatmentonrestingstatefunctionalconnectivityoflargescalebrainnetworksinmajordepressivedisorder
AT cuijian effectsof12weekescitalopramtreatmentonrestingstatefunctionalconnectivityoflargescalebrainnetworksinmajordepressivedisorder
AT zhangzhifang effectsof12weekescitalopramtreatmentonrestingstatefunctionalconnectivityoflargescalebrainnetworksinmajordepressivedisorder
AT liurui effectsof12weekescitalopramtreatmentonrestingstatefunctionalconnectivityoflargescalebrainnetworksinmajordepressivedisorder
AT fengyuan effectsof12weekescitalopramtreatmentonrestingstatefunctionalconnectivityoflargescalebrainnetworksinmajordepressivedisorder
AT fenglei effectsof12weekescitalopramtreatmentonrestingstatefunctionalconnectivityoflargescalebrainnetworksinmajordepressivedisorder
AT wangyun effectsof12weekescitalopramtreatmentonrestingstatefunctionalconnectivityoflargescalebrainnetworksinmajordepressivedisorder
AT chenxiongying effectsof12weekescitalopramtreatmentonrestingstatefunctionalconnectivityoflargescalebrainnetworksinmajordepressivedisorder
AT wuhang effectsof12weekescitalopramtreatmentonrestingstatefunctionalconnectivityoflargescalebrainnetworksinmajordepressivedisorder
AT jinyuening effectsof12weekescitalopramtreatmentonrestingstatefunctionalconnectivityoflargescalebrainnetworksinmajordepressivedisorder
AT zhouyuan effectsof12weekescitalopramtreatmentonrestingstatefunctionalconnectivityoflargescalebrainnetworksinmajordepressivedisorder
AT wanggang effectsof12weekescitalopramtreatmentonrestingstatefunctionalconnectivityoflargescalebrainnetworksinmajordepressivedisorder